Cargando…
Deconvoluting cellular neighborhoods in pancreatic ductal adenocarcinoma
Pancreatic ductal adenocarcinoma (PDAC) is one of the most aggressive cancers, with less than 10% of patients surviving more than five years. A major challenge of PDAC is understanding the complexity of the tumor architecture and identifying targetable cellular phenotypes that can inform clinical de...
Autor principal: | Lal, Jessica Castrillon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9576745/ https://www.ncbi.nlm.nih.gov/pubmed/36253462 http://dx.doi.org/10.1038/s42003-022-04032-1 |
Ejemplares similares
-
Targeting chemokines/chemokine receptors: a promising strategy for enhancing the immunotherapy of pancreatic ductal adenocarcinoma
por: Gong, Ruining, et al.
Publicado: (2020) -
Bispecific immune molecule PD1-IL2v: a new therapeutic strategy for pancreatic ductal adenocarcinoma
por: Gao, Yuan, et al.
Publicado: (2023) -
Cellular heterogeneity in pancreatic cancer: the different faces of gremlin action
por: Moustakas, Aristidis, et al.
Publicado: (2022) -
Cellular and molecular mechanisms of perineural invasion of pancreatic ductal adenocarcinoma
por: Li, Jingbo, et al.
Publicado: (2021) -
Organoid-based chemical approach to dissect the mechanism controlling cellular dynamics
por: Lacko, Lauretta A, et al.
Publicado: (2019)